Hemogenyx utilizes postnatal human hemogenic endothelial cells (Hu-PHEC cells), discovered by Hemogenyx Co-Founder Dr Vladislav Sandler, to generate cancer-free hematopoietic stem cells (HSC) for use in transplants to treat blood cancers with superior results. A patent for Dr Sandler’s work was issued in the US in February 2020. Hu-PHEC-based technology presents a number of important … Continue reading Hu-PHEC